A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Role of Variance in Interferon Genes to Disease Severity in COVID-19 Patients
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-17
DOI
10.3389/fgene.2021.709388
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- (2021) Asim Zahoor Abbasi et al. JOURNAL OF MEDICAL VIROLOGY
- Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
- (2021) Jordan J Feld et al. Lancet Respiratory Medicine
- Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
- (2021) Prasanna Jagannathan et al. Nature Communications
- Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals
- (2021) Jack A. Kosmicki et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Association between Interferon-Lambda-3 rs12979860, TLL1 rs17047200 and DDR1 rs4618569 Variant Polymorphisms with the Course and Outcome of SARS-CoV-2 Patients
- (2021) Sara H. A. Agwa et al. Genes
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- (2020) Yanan Cao et al. Cell Discovery
- Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia
- (2020) Juyi Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Tool for Early Prediction of Severe Coronavirus Disease 2019 (COVID-19): A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China
- (2020) Jiao Gong et al. CLINICAL INFECTIOUS DISEASES
- COVID ‐19: lambda interferon against viral load and hyperinflammation
- (2020) Evangelos Andreakos et al. EMBO Molecular Medicine
- The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic
- (2020) EUROPEAN JOURNAL OF HUMAN GENETICS
- Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study
- (2020) Rong-Hui Du et al. EUROPEAN RESPIRATORY JOURNAL
- The ACE-2 in COVID-19: Foe or Friend?
- (2020) Rinkoo Dalan et al. HORMONE AND METABOLIC RESEARCH
- COVID-19 and emerging viral infections: The case for interferon lambda
- (2020) Ludmila Prokunina-Olsson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clinical course and mortality risk of severe COVID-19
- (2020) Paul Weiss et al. LANCET
- COVID-19 and smoking: A systematic review of the evidence
- (2020) Constantine Vardavas et al. Tobacco Induced Diseases
- COVID-19 in patients with HIV
- (2020) Rachael Jones et al. Lancet HIV
- Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020
- (2020) et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
- (2020) Shikha Garg et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Type 1 interferons as a potential treatment against COVID-19
- (2020) Erwan Sallard et al. ANTIVIRAL RESEARCH
- Anti‐A isohaemagglutinin titres and SARS‐CoV‐2 neutralization: implications for children and convalescent plasma selection
- (2020) Daniele Focosi BRITISH JOURNAL OF HAEMATOLOGY
- COVID-19 and Liver
- (2020) Dinesh Jothimani et al. JOURNAL OF HEPATOLOGY
- Likelihood of survival of coronavirus disease 2019
- (2020) Shigui Ruan LANCET INFECTIOUS DISEASES
- Estimates of the severity of coronavirus disease 2019: a model-based analysis
- (2020) Robert Verity et al. LANCET INFECTIOUS DISEASES
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells
- (2020) Megan L. Stanifer et al. Cell Reports
- Could Sex/Gender Differences in ACE2 Expression in the Lungs Contribute to the Large Gender Disparity in the Morbidity and Mortality of Patients Infected With the SARS-CoV-2 Virus?
- (2020) Gregor Majdic Frontiers in Cellular and Infection Microbiology
- No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate Coronavirus Disease 2019: Results of a Randomized, Open-Labeled Prospective Study
- (2020) Yin-Qiu Huang et al. Frontiers in Pharmacology
- Lack of Association Between Genetic Variants at ACE2 and TMPRSS2 Genes Involved in SARS-CoV-2 Infection and Human Quantitative Phenotypes
- (2020) Esteban A. Lopera Maya et al. Frontiers in Genetics
- Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
- (2020) Kumari G. Lokugamage et al. JOURNAL OF VIROLOGY
- The major genetic risk factor for severe COVID-19 is inherited from Neanderthals
- (2020) Hugo Zeberg et al. NATURE
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells
- (2020) Andrea Latini et al. Genes
- The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
- (2020) Ryan L. Hoiland et al. Blood Advances
- Genetic mechanisms of critical illness in Covid-19
- (2020) Erola Pairo-Castineira et al. NATURE
- Dysregulated Interferon Response Underlying Severe COVID-19
- (2020) LeAnn Lopez et al. Viruses-Basel
- SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress
- (2020) Wasco Wruck et al. Scientific Reports
- A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
- (2020) Béla Nagy et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The flexibility of ACE2 in the context of SARS-CoV-2 infection
- (2020) Emilia P. Barros et al. BIOPHYSICAL JOURNAL
- IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
- (2018) Jonas Klinkhammer et al. eLife
- Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling
- (2017) Keaton M. Crosse et al. Journal of Innate Immunity
- IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection
- (2017) Pil Soo Sung et al. Scientific Reports
- Impact of the Type I Interferon Receptor on the Global Gene Expression Program During the Course of Dendritic Cell Maturation Induced by Polyinosinic Polycytidylic Acid
- (2016) Amy L. Olex et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- IFNL4 rs368234815 polymorphism is associated with innate resistance to HIV-1 infection
- (2015) Luis M. Real et al. AIDS
- LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants: Fig. 1.
- (2015) Mitchell J. Machiela et al. BIOINFORMATICS
- IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals
- (2015) K. Machmach et al. CLINICAL MICROBIOLOGY AND INFECTION
- Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells
- (2015) C Lauber et al. GENES AND IMMUNITY
- Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
- (2015) Helen M. Lazear et al. IMMUNITY
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- The Chemokine System in Innate Immunity
- (2015) Caroline L. Sokol et al. Cold Spring Harbor Perspectives in Biology
- The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients
- (2014) Stéphanie Bibert et al. AIDS
- Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
- (2014) Raphael N. Vuille-dit-Bille et al. AMINO ACIDS
- Interferon-Stimulated Genes: A Complex Web of Host Defenses
- (2014) William M. Schneider et al. Annual Review of Immunology
- Interferons: Success in anti-viral immunotherapy
- (2014) Fan-ching Lin et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Poster Sessions
- (2014) HEPATOLOGY
- A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
- (2014) Andrew J. Muir et al. JOURNAL OF HEPATOLOGY
- Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
- (2014) Adrian Egli et al. JOURNAL OF INFECTIOUS DISEASES
- Lymphocytes Degranulation in Liver in Hepatitis C Virus Carriers Is Associated With IFNL4 Polymorphisms and ALT Levels
- (2014) Evelyne Jouvin-Marche et al. JOURNAL OF INFECTIOUS DISEASES
- Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation
- (2014) Oriol Manuel et al. JOURNAL OF INFECTIOUS DISEASES
- IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
- (2014) Thomas R. O'Brien et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Role of Type I Interferon Receptor Signaling on NK Cell Development and Functions
- (2014) Jean Guan et al. PLoS One
- Selection on a Variant Associated with Improved Viral Clearance Drives Local, Adaptive Pseudogenization of Interferon Lambda 4 (IFNL4)
- (2014) Felix M. Key et al. PLoS Genetics
- IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients
- (2013) Sandra Franco et al. AIDS
- Polymorphisms of interferon-λ4andIL28B- effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C
- (2013) A. F. Stättermayer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts
- (2013) Priya Duggal et al. ANNALS OF INTERNAL MEDICINE
- Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
- (2013) Ole J Hamming et al. EMBO JOURNAL
- Type I IFNs Regulate Effector and Regulatory T Cell Accumulation and Anti-Inflammatory Cytokine Production during T Cell-Mediated Colitis
- (2013) A. Kole et al. JOURNAL OF IMMUNOLOGY
- IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin
- (2013) Eric G. Meissner et al. JOURNAL OF INFECTIOUS DISEASES
- Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
- (2013) Peter V. Aka et al. JOURNAL OF INFECTIOUS DISEASES
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- Interferon-λ4 (IFNL4) Transcript Expression in Human Liver Tissue Samples
- (2013) Ahmad Amanzada et al. PLoS One
- Genetic polymorphism inIFNL4and response to pegylated interferon-α and ribavirin in Japanese chronic hepatitis C patients
- (2013) Y. Nozawa et al. TISSUE ANTIGENS
- IL28B Single-Nucleotide Polymorphism rs12979860 Is Associated With Spontaneous HIV Control in White Subjects
- (2012) Kawthar Machmach et al. JOURNAL OF INFECTIOUS DISEASES
- The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin
- (2012) Zobair M Younossi et al. Journal of Translational Medicine
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- IL28B Genotype Does Not Correlate with HIV Control in African Americans
- (2011) Mohammad M. Sajadi et al. CTS-Clinical and Translational Science
- Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African–American elite controllers/suppressors
- (2010) Maria Salgado et al. AIDS
- Interferon-Lambda: A New Addition to an Old Family
- (2010) Raymond P. Donnelly et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interferon-λ Is Functionally an Interferon but Structurally Related to the Interleukin-10 Family
- (2009) Hans Henrik Gad et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
- (2009) David L. Thomas et al. NATURE
- IFNγ signaling—Does it mean JAK–STAT?
- (2008) Daniel J. Gough et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Tissue-Specific Amino Acid Transporter Partners ACE2 and Collectrin Differentially Interact With Hartnup Mutations
- (2008) Simone M.R. Camargo et al. GASTROENTEROLOGY
- Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
- (2008) Patrice Guillon et al. GLYCOBIOLOGY
- Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
- (2007) R. E. Randall et al. JOURNAL OF GENERAL VIROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started